Status:
COMPLETED
Observational Study to Evaluate Risks of Side Effects, Drug Abuse and Dependence in Patients Who Received Xyrem ® on Prescription
Lead Sponsor:
UCB Pharma
Conditions:
Narcolepsy
Eligibility:
All Genders
Brief Summary
Patients will be followed up for max 18 months. Information on the Adverse Events and potential misuse or abuse of Xyrem ® will be collected.
Eligibility Criteria
Inclusion
- Patients who received Xyrem ® on prescription
Exclusion
- No limitations
Key Trial Info
Start Date :
May 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2016
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT00244465
Start Date
May 1 2006
End Date
September 1 2016
Last Update
September 7 2016
Active Locations (41)
Enter a location and click search to find clinical trials sorted by distance.
1
9
Graz, Austria
2
5
Innsbruck, Austria
3
12
Antwerp, Belgium
4
28
Bruges, Belgium